Solomon Moshkevich - 02 Nov 2026 Form 4 Insider Report for Natera, Inc. (NTRA)

SEC form
4
Accepted by SEC
04 Nov 2026, 21:35:13 UTC
Prior SEC filing
29 Oct 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Solomon Moshkevich filed Form 4 for Natera, Inc. (NTRA) on 04 Nov 2026.

Key facts

  • This page summarizes Solomon Moshkevich's Form 4 filing for Natera, Inc. (NTRA).
  • 12 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 21:35.

Change

  • Previous filing in this sequence was filed on 29 Oct 2026.
  • Current net transaction value: -$1,400,994.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010019 Primary reporting owner

Moshkevich Solomon

Relationship
PRESIDENT, CLINICALDIAGNOSTICS

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Sale

Transaction value
-$3,494
Shares
-9
Change %
-0.01%
Price
$388.20
Shares after
104,733
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
NTRA transaction

Common Stock

Sale

Transaction value
-$164,121
Shares
-410
Change %
-0.39%
Price
$400.29
Shares after
104,323
Date
02 Nov 2026
Ownership
Direct
Footnotes
F1
NTRA transaction

Common Stock

Sale

Transaction value
-$81,051
Shares
-200
Change %
-0.19%
Price
$405.26
Shares after
104,123
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F3
NTRA transaction

Common Stock

Sale

Transaction value
-$175,798
Shares
-432
Change %
-0.41%
Price
$406.94
Shares after
103,691
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F4
NTRA transaction

Common Stock

Sale

Transaction value
-$166,498
Shares
-408
Change %
-0.39%
Price
$408.08
Shares after
103,283
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F5
NTRA transaction

Common Stock

Sale

Transaction value
-$212,918
Shares
-520
Change %
-0.5%
Price
$409.46
Shares after
102,763
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F6
NTRA transaction

Common Stock

Sale

Transaction value
-$49,286
Shares
-120
Change %
-0.12%
Price
$410.72
Shares after
102,643
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F7
NTRA transaction

Common Stock

Sale

Transaction value
-$49,408
Shares
-120
Change %
-0.12%
Price
$411.73
Shares after
102,523
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F8
NTRA transaction

Common Stock

Sale

Transaction value
-$49,546
Shares
-120
Change %
-0.12%
Price
$412.88
Shares after
102,403
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F9
NTRA transaction

Common Stock

Sale

Transaction value
-$33,133
Shares
-80
Change %
-0.08%
Price
$414.16
Shares after
102,323
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F10
NTRA transaction

Common Stock

Sale

Transaction value
-$315,795
Shares
-760
Change %
-0.74%
Price
$415.52
Shares after
101,563
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F11
NTRA transaction

Common Stock

Sale

Transaction value
-$99,947
Shares
-240
Change %
-0.24%
Price
$416.45
Shares after
101,323
Date
02 Nov 2026
Ownership
Direct
Footnotes
F2, F12
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 12 footnotes

Footnote F1

The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.

Footnote F2

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.

Footnote F3

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.8500 to $405.8450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.4150 to $407.3750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.5550 to $408.4100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.13 to $409.94 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $410.21 to $411.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $411.4300 to $411.8850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.6200 to $413.0150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.8100 to $414.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F11

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.9450 to $415.6400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F12

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.18 to $416.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .